CIK 0001812364
- Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 43,168 shares at $7.82 ($337,574)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 62,073 shares at $7.00 ($434,511)
- 4 Open-market sale See remarks sold 40,529 shares at an average $7.40 ($299,949)
- 4 Open-market sale Chief Financial Officer sold 21,664 shares at $7.29 ($157,931)
- 4 Open-market sale President, R&D sold 30,897 shares at $7.29 ($225,239)
- 4 Open-market sale See remarks sold 17,083 shares at an average $3.68 ($62,947)
- 4 Open-market sale Chief Financial Officer sold 20,081 shares at an average $3.69 ($74,000)
- 4 Open-market sale President, R&D sold 30,770 shares at an average $3.69 ($113,478)
- 4 Open-market sale Chief Legal Officer sold 19,913 shares at an average $3.68 ($73,378)
- 4 Open-market sale President and CEO sold 61,379 shares at $3.57 ($219,123)
- 4 Grant or award See remarks acquired 5,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 5,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 3 of 16 · 320 filings